This compound is a pharmaceutical intermediate used in the synthesis of impurities related to adenosine monophosphate. It features a complex structure containing purine and amino acid moieties, with multiple polar functional groups contributing to its hydrophilic nature.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-(-)-Trityl glycidyl ether
pharmaceutical intermediate
Pamoic acid
pharmaceutical intermediate
1-(4-Chlorobenzhydryl)piperazine
pharmaceutical intermediate
3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
pharmaceutical intermediate
2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoic acid
JISVTSUBJCPLSV-HVMNINKTSA-N
CN(CCC(C(=O)O)N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.